Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 4/20 | 0.52 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL186842 | 0.94 | GABRA1 (0.52) | PTGS1BACE1KIF11CES2GABRA1 | |
| Water SCHEMBL21493255 | 0.91 | GABRA1 (0.50) | PTGS1BACE1KIF11CES2GABRA1 | |
| SCHEMBL29886876 | 0.91 | CES2 (0.56) | PTGS1BACE1KIF11CES2GABRA1 | |
| SCHEMBL29384937 | 0.91 | GABRA1 (0.50) | PTGS1BACE1KIF11CES2GABRA1 | |
| SCHEMBL29005991 | 0.91 | GABRA1 (0.50) | PTGS1BACE1KIF11CES2GABRA1 | |
| SCHEMBL29170632 | 0.88 | CES2 (0.48) | PTGS1BACE1KIF11CES2GABRA1 | |
| SCHEMBL8999890 | 0.86 | KIF11 (0.46) | PTGS1BACE1KIF11CES2GABRA1 | |
| SCHEMBL29319988 | 0.84 | RXRA (0.48) | PTGS1BACE1KIF11CES2GABRA1 | |
| SCHEMBL29452900 | 0.84 | CA12 (0.57) | PTGS1BACE1KIF11CES2GABRA1 | |
| SCHEMBL77464 | 0.84 | CA12 (0.57) | PTGS1BACE1KIF11CES2GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118949689-A | Amphoteric ion modified fluorine-containing poly (ester) amide thin layer composite reverse osmosis membrane, and preparation method and application thereof | 天津工业大学绍兴柯桥研究院 | 2024-11-15 | — | — | CN | claimed |
| CN-118615887-A | Fluorine-containing poly (ester) amide thin layer composite reverse osmosis membrane, and preparation method and application thereof | 天津工业大学绍兴柯桥研究院 | 2024-09-10 | — | — | CN | claimed |
| CN-101270054-A | Method for preparing 3,5-bis(2,6-di-nitryl-4-trifluoromethyl phenoxy group) toluene trifluoride | UNIV DONGHUA (CN) | 2008-09-24 | — | — | CN | claimed |
| CN-101234980-A | Method for preparing 3,5-di(2,4-dinitrophenoxy)trifluorotoluene | UNIV DONGHUA (CN) | 2008-08-06 | — | — | CN | claimed |
| EP-4651955-A1 | INHIBITOR COMPOUNDS | Neophore Limited (GB) | 2025-11-26 | — | — | EP | disclosed |
| CN-118949689-A | Amphoteric ion modified fluorine-containing poly (ester) amide thin layer composite reverse osmosis membrane, and preparation method and application thereof | 天津工业大学绍兴柯桥研究院 | 2024-11-15 | — | — | CN | disclosed |
| CN-118615887-A | Fluorine-containing poly (ester) amide thin layer composite reverse osmosis membrane, and preparation method and application thereof | 天津工业大学绍兴柯桥研究院 | 2024-09-10 | — | — | CN | disclosed |
| EP-4419532-A1 | FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2024-08-28 | — | — | EP | disclosed |
| US-20240279237-A1 | FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2024-08-22 | — | — | US | disclosed |
| WO-2024153947-A1 | INHIBITOR COMPOUNDS | Neophore Limited (GB) | 2024-07-25 | — | — | WO | disclosed |
| US-20240239931-A1 | FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS | CHEMOURS COMPANY FC, LLC, THE | 2024-07-18 | — | — | US | disclosed |
| US-20240239931-A1 | FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS | CHEMOURS COMPANY FC, LLC, THE | 2024-07-18 | — | — | US | disclosed |
| US-20110092662-A1 | AROMATIC POLYESTER | NITTA CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| CN-101875606-A | Synthetic method of 2,6-dihydroxyterephthalic acid | UNIV ZHEJIANG TECHNOLOGY | 2010-11-03 | — | — | CN | disclosed |
| CN-101270054-A | Method for preparing 3,5-bis(2,6-di-nitryl-4-trifluoromethyl phenoxy group) toluene trifluoride | UNIV DONGHUA (CN) | 2008-09-24 | — | — | CN | disclosed |
| CN-101270054-A | Method for preparing 3,5-bis(2,6-di-nitryl-4-trifluoromethyl phenoxy group) toluene trifluoride | UNIV DONGHUA (CN) | 2008-09-24 | — | — | CN | disclosed |
| CN-101234980-A | Method for preparing 3,5-di(2,4-dinitrophenoxy)trifluorotoluene | UNIV DONGHUA (CN) | 2008-08-06 | — | — | CN | disclosed |
| CN-101234980-A | Method for preparing 3,5-di(2,4-dinitrophenoxy)trifluorotoluene | UNIV DONGHUA (CN) | 2008-08-06 | — | — | CN | disclosed |
| US-7208559-B2 | Ethylened polymer and molded object obtained therefrom | MITSUI CHEMICALS, INC. (JP) | 2007-04-24 | — | — | US | disclosed |
| US-20060135712-A1 | Ethylened polymer and molded object obtained therefrom | MITSUI CHEMICALS, INC. (JP) | 2006-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240279237-A1 | FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS NLRP3 INHIBITORS | NLRP3, NOD1, NLRP1 | PTGS1 1804/4885BACE1 108/4885KIF11 4471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.